golimumab,infliximab,bimekizumab
ucb pharmaceuticals,janssen
['infliximab', 'golimumab', 'bimekizumab']
psa bdmard "ranking" system by systematic literature review looked at 30 rcts
highest probability of achieving acr20 and pasi90: infliximab, golimumab and bimekizumab
#acrbest abs#2123 #acr22 
Rheumatologist. Amateur chef. YNWA. Views and opinions are my own.